An introduction to Cardiovascular diseasesReferences

Acknowledgements

This evidence summary was written by:

William B. Grant, Ph.D.
Sunlight, Nutrition, and Health Research Center (SUNARC)
P.O. Box 641603
San Francisco, CA 94164-1603, USA      
www.sunarc.org      
wbgrant@infionline.net

123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101

Page last edited: 04 May 2011

References

  1. Alsafwah, S. Laguardia, S. P. Arroyo, M. Dockery, B. K. Bhattacharya, S. K. Ahokas, R. A. Newman, K. P. Congestive heart failure is a systemic illness: a role for minerals and micronutrients. Clin Med Res. 2007 Dec; 5 (4): 238-43.
  2. Anagnostis, P. Athyros, V. G. Adamidou, F. Florentin, M. Karagiannis, A. Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk?. Curr Vasc Pharmacol. 2010 Sep; 8 (5): 720-30.
  3. Artaza, J. N. Mehrotra, R. Norris, K. C. Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol. 2009 Sep; 4 (9): 1515-22.
  4. Ballermann, B. J. Zeidel, M. L. Gunning, M. E. Brenner, B. M. Vasoactive peptides and the kidney. The kidney. 1991; pp. 510-583.
  5. Barnett, A. G. de Looper, M. Fraser, J. F. The seasonality in heart failure deaths and total cardiovascular deaths. Aust N Z J Public Health. 2008 Oct; 32 (5): 408-13.
  6. Baz-Hecht, M. Goldfine, A. B. The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr Opin Endocrinol Diabetes Obes. 2010 Apr; 17 (2): 113-9.
  7. Bonakdaran, S. Varasteh, A. R. Correlation between serum 25 hydroxy vitamin D3 and laboratory risk markers of cardiovascular diseases in type 2 diabetic patients. Saudi Med J. 2009 Apr; 30 (4): 509-14.
  8. Brancaccio, D. Bellasi, A. Cozzolino, M. Galassi, A. Gallieni, M. Arterial accelerated aging in dialysis patients: the clinical impact of vascular calcification. Curr Vasc Pharmacol. 2009 Jul; 7 (3): 374-80.
  9. Brancaccio, D. Bommer, J. Coyne, D. Vitamin D receptor activator selectivity in the treatment of secondary hyperparathyroidism: understanding the differences among therapies. Drugs. 2007; 67 (14): 1981-98.
  10. Cannell, J. J. Vieth, R. Umhau, J. C. Holick, M. F. Grant, W. B. Madronich, S. Garland, C. F. Giovannucci, E. Epidemic influenza and vitamin D. Epidemiol Infect. 2006 Dec; 134 (6): 1129-40.
  11. Chen, S. Law, C. S. Gardner, D. G. Vitamin D-dependent suppression of endothelin-induced vascular smooth muscle cell proliferation through inhibition of CDK2 activity. J Steroid Biochem Mol Biol. 2010 Feb 15; 118 (3): 135-41.
  12. Covic, A. Kanbay, M. Voroneanu, L. Turgut, F. Serban, D. N. Serban, I. L. Goldsmith, D. J. Vascular calcification in chronic kidney disease. Clin Sci (Lond). 2010 Aug; 119 (3): 111-21.
  13. Cozzolino, M. Biondi, M. L. Galassi, A. Cusi, D. Brancaccio, D. Gallieni, M. Vascular calcification and cardiovascular outcome in dialysis patients: the role of gene polymorphisms. Blood Purif. 2010; 29 (4): 347-51.
  14. Crombie, D. L. Fleming, D. M. Cross, K. W. Lancashire, R. J. Concurrence of monthly variations of mortality related to underlying cause in Europe. J Epidemiol Community Health. 1995 Aug; 49 (4): 373-8.
  15. Danziger, J. Vitamin K-dependent proteins, warfarin, and vascular calcification. Clin J Am Soc Nephrol. 2008 Sep; 3 (5): 1504-10.
  16. de Boer, I. H. Kestenbaum, B. Shoben, A. B. Michos, E. D. Sarnak, M. J. Siscovick, D. S. 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol. 2009 Aug; 20 (8): 1805-12.
  17. Derosa, G. D’Angelo, A. Scalise, F. Avanzini, M. A. Tinelli, C. Peros, E. Fogari, E. Cicero, A. F. Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome. Heart Vessels. 2007 Nov; 22 (6): 361-70.
  18. Diaz, L et al. Calcitriol inhibits TNF-alpha-induced inflammatory cytokines in human trophoblasts. J Reprod Immunol. 2009 Jul; 81 (8): 17-24.
  19. Dobnig, H. Pilz, S. Scharnagl, H. Renner, W. Seelhorst, U. Wellnitz, B. Kinkeldei, J. Boehm, B. O. Weihrauch, G. Maerz, W. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008 Jun 23; 168 (12): 1340-9.
  20. Douglas, A. S. al-Sayer, H. Rawles, J. M. Allan, T. M. Seasonality of disease in Kuwait. Lancet. 1991 Jun 8; 337 (8754): 1393-7.
  21. Douglas, A. S. Dunnigan, M. G. Allan, T. M. Rawles, J. M. Seasonal variation in coronary heart disease in Scotland. J Epidemiol Community Health. 1995 Dec; 49 (6): 575-82.
  22. Douglas, S. Rawles, J. Latitude-related changes in the amplitude of annual mortality rhythm. The biological equator in man. Chronobiol Int. 1999 Mar; 16 (2): 199-212.
  23. Dusso, A. Arcidiacono, M. V. Yang, J. Tokumoto, M. Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality. J Steroid Biochem Mol Biol. 2010 Jul; 121 (1-2): 193-8.
  24. El-Abbadi, M. Giachelli, C. M. Mechanisms of vascular calcification. Adv Chronic Kidney Dis. 2007 Jan; 14 (1): 54-66.
  25. Ertugrul, D. T. Yavuz, B. Cil, H. Ata, N. Akin, K. O. Kucukazman, M. Yalcin, A. A. Dal, K. Yavuz, B. B. Tutal, E. STATIN-D Study: Comparison of the Influences of Rosuvastatin and Fluvastatin Treatment on the Levels of 25 Hydroxyvitamin D. Cardiovasc Ther. 2010 Mar 27;
  26. Fiscella, K. Franks, P. Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med. 2010 Jan-Feb; 8 (1): 11-8.
  27. Forman, J. P. Bischoff-Ferrari, H. A. Willett, W. C. Stampfer, M. J. Curhan, G. C. Vitamin D intake and risk of incident hypertension: results from three large prospective cohort studies. Hypertension. 2005 Oct; 46 (4): 676-82.
  28. Forman, J. P. Curhan, G. C. Taylor, E. N. Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension Among Young Women. Hypertension. 2008 Oct 6;
  29. Forman, J. P. Giovannucci, E. Holmes, M. D. Bischoff-Ferrari, H. A. Tworoger, S. S. Willett, W. C. Curhan, G. C. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007 May; 49 (5): 1063-9.
  30. Gao, X. Picchi, A. Zhang, C. Upregulation of TNF-alpha and Receptors Contribute to Endothelial Dysfunction in Zucker Diabetic Rats. Am J Biomed Sci. 2010; 2 (1): 1-12.
  31. Ginde, A. A. Scragg, R. Schwartz, R. S. Camargo, C. A., Jr. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc. 2009 Sep; 57 (9): 1595-603.
  32. Giovannucci, E. Vitamin D and cardiovascular disease. Curr Atheroscler Rep. 2009 Nov; 11 (6): 456-61.
  33. Giovannucci, E. Liu, Y. Hollis, B. W. Rimm, E. B. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008 Jun 9; 168 (11): 1174-80.
  34. Gouni-Berthold, I. Krone, W. Berthold, H. K. Vitamin D and cardiovascular disease. Curr Vasc Pharmacol. 2009 Jul; 7 (3): 414-22.
  35. Gupta, R. Sharma, U. Gupta, N. Kalaivani, M. Singh, U. Guleria, R. Jagannathan, N. R. Goswami, R. Effect of cholecalciferol and calcium supplementation on muscle strength and energy metabolism in vitamin D deficient Asian Indians: A randomized controlled trial. Clin Endocrinol (Oxf). 2010 Apr 23;
  36. Heaney, R. P. Davies, K. M. Chen, T. C. Holick, M. F. Barger-Lux, M. J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003 Jan; 77 (1): 204-10.
  37. Hsu, J. J. Tintut, Y. Demer, L. L. Vitamin D and osteogenic differentiation in the artery wall. Clin J Am Soc Nephrol. 2008 Sep; 3 (5): 1542-7.
  38. Hypponen, E. Boucher, B. J. Berry, D. J. Power, C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes. 2008 Feb; 57 (2): 298-305.
  39. Johnson, R. C. Leopold, J. A. Loscalzo, J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res. 2006 Nov 10; 99 (10): 1044-59.
  40. Judd, S. E. Nanes, M. S. Ziegler, T. R. Wilson, P. W. Tangpricha, V. Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr. 2008 Jan; 87 (1): 136-41.
  41. Judd, S. E. Tangpricha, V. Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci. 2009 Jul; 338 (1): 40-4.
  42. Kalpakian, M. A. Mehrotra, R. Vascular calcification and disordered mineral metabolism in dialysis patients. Semin Dial. 2007 Mar-Apr; 20 (2): 139-43.
  43. Kendrick, J. Targher, G. Smits, G. Chonchol, M. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis. 2009 Jul; 205 (1): 255-60.
  44. Kilkkinen, A. Knekt, P. Aro, A. Rissanen, H. Marniemi, J. Heliovaara, M. Impivaara, O. Reunanen, A. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol. 2009 Oct 15; 170 (8): 1032-9.
  45. Kim, D. H. Sabour, S. Sagar, U. N. Adams, S. Whellan, D. J. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol. 2008 Dec 1; 102 (11): 1540-4.
  46. Lappe J M et al Vitamin D status in a rural postmenopausal female population. J Am Coll Nutr. 2006 Oct; 25 (5): 395-402.
  47. Laxton, R. C. Hu, Y. Duchene, J. Zhang, F. Zhang, Z. Leung, K. Y. Xiao, Q. Scotland, R. S. Hodgkinson, C. P. Smith, K. Willeit, J. Lopez-Otin, C. Simpson, I. A. Kiechl, S. Ahluwalia, A. Xu, Q. Ye, S. A role of matrix metalloproteinase-8 in atherosclerosis. Circ Res. 2009 Oct 23; 105 (9): 921-9.
  48. London, G. M. Guerin, A. P. Verbeke, F. H. Pannier, B. Boutouyrie, P. Marchais, S. J. Metivier, F. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol. 2007 Feb; 18 (2): 613-20.
  49. Lowe, G. D. Danesh, J. Lewington, S. Walker, M. Lennon, L. Thomson, A. Rumley, A. Whincup, P. H. Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis. Eur Heart J. 2004 Feb; 25 (3): 252-9.
  50. Luong, K. V. Nguyen, L. T. Vitamin D and cardiovascular disease. Curr Med Chem. 2006; 13 (20): 2443-7.
  51. Mallat, Z. Matrix metalloproteinase-8 and the regulation of blood pressure, vascular inflammation, and atherosclerotic lesion growth. Circ Res. 2009 Oct 23; 105 (9): 827-9.
  52. Mallat, Z. Taleb, S. Ait-Oufella, H. Tedgui, A. The role of adaptive T cell immunity in atherosclerosis. J Lipid Res. 2009 Apr; 50 SupplS364-9.
  53. Manrique, C. Lastra, G. Gardner, M. Sowers, J. R. The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress. Med Clin North Am. 2009 May; 93 (3): 569-82.
  54. Melamed, M. L. Michos, E. D. Post, W. Astor, B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008 Aug 11; 168 (15): 1629-37.
  55. Melamed, M. L. Muntner, P. Michos, E. D. Uribarri, J. Weber, C. Sharma, J. Raggi, P. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol. 2008 Jun; 28 (6): 1179-85.
  56. Mertens, P. R. Muller, R. Vitamin D and cardiovascular risk. Int Urol Nephrol. 2010 Mar; 42 (1): 165-71.
  57. Michos, E. D. Melamed, M. L. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care. 2008 Jan; 11 (1): 7-12.
  58. Mizobuchi, M. Ogata, H. Koiwa, F. Kinugasa, E. Akizawa, T. Vitamin D and vascular calcification in chronic kidney disease. Bone. 2009 Jul; 45 Suppl 1S26-9.
  59. Nemerovski, C. W. Dorsch, M. P. Simpson, R. U. Bone, H. G. Aaronson, K. D. Bleske, B. E. Vitamin D and cardiovascular disease. Pharmacotherapy. 2009 Jun; 29 (6): 691-708.
  60. Okazaki R et al Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D(3) load in Japanese subjects. J Bone Miner Metab. 2010 Jun; 22
  61. Parker, J. Hashmi, O. Dutton, D. Mavrodaris, A. Stranges, S. Kandala, N. B. Clarke, A. Franco, O. H. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas. 2010 Mar; 65 (3): 225-36.
  62. Perez-Lopez, F. R. Vitamin D metabolism and cardiovascular risk factors in postmenopausal women. Maturitas. 2009 Mar 20; 62 (3): 248-62.
  63. Petchey, W. G. Hickman, I. J. Duncan, E. Prins, J. B. Hawley, C. M. Johnson, D. W. Barraclough, K. Isbel, N. M. The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial. BMC Nephrol. 2009; 1041.
  64. Pilz, S. Tomaschitz, A. Ritz, E. Pieber, T. R. Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol. 2009 Oct; 6 (10): 621-30.
  65. Pittas, A. G. Chung, M. Trikalinos, T. Mitri, J. Brendel, M. Patel, K. Lichtenstein, A. H. Lau, J. Balk, E. M. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010 Mar 2; 152 (5): 307-14.
  66. Pittas, A. G. Harris, S. S. Stark, P. C. Dawson-Hughes, B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007 Apr; 30 (4): 980-6.
  67. Reis, J. P. Michos, E. D. von Muhlen, D. Miller, E. R., 3rd Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am J Clin Nutr. 2008 Dec; 88 (6): 1469-77.
  68. Reis, J. P. von Muhlen, D. Michos, E. D. Miller, E. R., 3rd Appel, L. J. Araneta, M. R. Barrett-Connor, E. Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis. 2009 Dec; 207 (2): 585-90.
  69. Reis, J. P. von Muhlen, D. Miller, E. R., 3rd Michos, E. D. Appel, L. J. Vitamin D Status and Cardiometabolic Risk Factors in the United States Adolescent Population. Pediatrics. 2009 Aug 3;
  70. Rostand, S. G. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension. 1997 Aug; 30 (2 Pt 1): 150-6.
  71. Schubert, L. DeLuca, H. F. Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency. Arch Biochem Biophys. 2010 Aug 15; 500 (2): 157-61.
  72. Scragg, R. Seasonality of cardiovascular disease mortality and the possible protective effect of ultra-violet radiation. Int J Epidemiol. 1981 Dec; 10 (4): 337-41.
  73. Semba, R. D. Houston, D. K. Bandinelli, S. Sun, K. Cherubini, A. Cappola, A. R. Guralnik, J. M. Ferrucci, L. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr. 2010 Feb; 64 (2): 203-9.
  74. Snijder, M. B. et al Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med. 2007 Jun; 261 (6): 558-65.
  75. S ood, A. Arora, R. Vitamin D deficiency and its correlations with increased cardiovascular incidences. Am J Ther. 2010 Jul-Aug; 17 (4): e105-9.
  76. Stewart, S. McIntyre, K. Capewell, S. McMurray, J. J. Heart failure in a cold climate. Seasonal variation in heart failure-related morbidity and mortality. J Am Coll Cardiol. 2002 Mar 6; 39 (5): 760-6.
  77. Sugden, J. A. Davies, J. I. Witham, M. D. Morris, A. D. Struthers, A. D. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med. 2008 Mar; 25 (3): 320-5.
  78. Takasu, H. Anti-osteoclastogenic action of active vitamin D. Nutr Rev. 2008 Oct; 66 (10 Suppl 2): S113-5.
  79. Tarcin, O. Yavuz, D. G. Ozben, B. Telli, A. Ogunc, A. V. Yuksel, M. Toprak, A. Yazici, D. Sancak, S. Deyneli, O. Akalin, S. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab. 2009 Oct; 94 (10): 4023-30.
  80. Timms, P. M. Mannan, N. Hitman, G. A. Noonan, K. Mills, P. G. Syndercombe-Court, D. Aganna, E. Price, C. P. Boucher, B. J. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?. QJM. 2002 Dec; 95 (12): 787-96.
  81. Urashima, M. Segawa, T. Okazaki, M. Kurihara, M. Wada, Y. Ida, H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 2010 May; 91 (5): 1255-60.
  82. Verhave, G. Siegert, C. E. Role of vitamin D in cardiovascular disease. Neth J Med. 2010 Mar; 68 (3): 113-8.
  83. Visvanathan, R. Chapman, I. Preventing sarcopaenia in older people. Maturitas. 2010 Aug; 66 (4): 383-8.
  84. Wallis, D. E. Penckofer, S. Sizemore, G. W. The “sunshine deficit” and cardiovascular disease. Circulation. 2008 Sep 30; 118 (14): 1476-85.
  85. Wang, L. Manson, J. E. Song, Y. Sesso, H. D. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010 Mar 2; 152 (5): 315-23.
  86. Wang, T. J. Pencina, M. J. Booth, S. L. Jacques, P. F. Ingelsson, E. Lanier, K. Benjamin, E. J. D’Agostino, R. B. Wolf, M. Vasan, R. S. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008 Jan 29; 117 (4): 503-11.
  87. Webb, A. R. Engelsen, O. Calculated ultraviolet exposure levels for a healthy vitamin D status. Photochem Photobiol. 2006 Nov-Dec; 82 (6): 1697-703.
  88. Weber, K. T. Weglicki, W. B. Simpson, R. U. Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium. Cardiovasc Res. 2009 Feb 15; 81 (3): 500-8.
  89. Welsh, P. Whincup, P. H. Papacosta, O. Wannamethee, S. G. Lennon, L. Thomson, A. Rumley, A. Lowe, G. D. Serum matrix metalloproteinase-9 and coronary heart disease: a prospective study in middle-aged men. QJM. 2008 Oct; 101 (10): 785-91.
  90. Witham, M. D. Nadir, M. A. Struthers, A. D. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens. 2009 Oct; 27 (10): 1948-54.
  91. Wu, P. W. Rhew, E. Y. Dyer, A. R. Dunlop, D. D. Langman, C. B. Price, H. Sutton-Tyrrell, K. McPherson, D. D. Edmundowicz, D. Kondos, G. T. Ramsey-Goldman, R. 25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum. 2009 Oct 15; 61 (10): 1387-95.
  92. Wu-Wong, J. R. Noonan, W. Nakane, M. Brooks, K. A. Segreti, J. A. Polakowski, J. S. Cox, B. Vitamin d receptor activation mitigates the impact of uremia on endothelial function in the 5/6 nephrectomized rats. Int J Endocrinol. 2010; 2010625852.
  93. Yavuz, B. Ertugrul, D. T. Cil, H. Ata, N. Akin, K. O. Yalcin, A. A. Kucukazman, M. Dal, K. Hokkaomeroglu, M. S. Yavuz, B. B. Tutal, E. Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins?. Cardiovasc Drugs Ther. 2009 Aug; 23 (4): 295-9.
  94. Zittermann, A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol. 2006 Sep; 92 (1): 39-48.
  95. Zittermann, A. Frisch, S. Berthold, H. K. Gotting, C. Kuhn, J. Kleesiek, K. Stehle, P. Koertke, H. Koerfer, R. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr. 2009 May; 89 (5): 1321-7.
  96. Zittermann, A. Gummert, J. F. Sun, vitamin D, and cardiovascular disease. J Photochem Photobiol B. 2010 Nov 3; 101 (2): 124-9.
  97. Zittermann, A. Koerfer, R. Vitamin D in the prevention and treatment of coronary heart disease. Curr Opin Clin Nutr Metab Care. 2008 Nov; 11 (6): 752-7.
  98. Zittermann, A. Koerfer, R. Protective and toxic effects of vitamin D on vascular calcification: clinical implications. Mol Aspects Med. 2008 Dec; 29 (6): 423-32.
  99. Zittermann, A. Schleithoff, S. S. Koerfer, R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr. 2005 Oct; 94 (4): 483-92.
  100. Zittermann, A. Schleithoff, S. S. Koerfer, R. Vitamin D and vascular calcification. Curr Opin Lipidol. 2007 Feb; 18 (1): 41-6.
  101. Walker, M. D. et al. Carotid vascular abnormalities in primary hyperparathyroidism. J Clin Endocrinol Metab. 2009 Oct; 94 (10): 3849-56.